Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|July 23, 2013
Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzymeJiyeong Kim, Su-Kyung Kim, Hwa-Kyung Kim, et al.
Archives of Pharmacal Research|October 6, 2016
Cytotoxicity of lipid-soluble ginseng extracts is attenuated by plasma membrane redox enzyme NQO1 through maintaining redox homeostasis and delaying apoptosis in human neuroblastoma cellsHwa-Kyung Kim, Tae Gen Son, Dong-Gyu Jo, et al.
Pharmaceutical Research|November 11, 2025
Exploration of 2-Mercaptoquinazolin-4(3H)-one Based N-Hydroxyheptanamides as Histone Deacetylase Inhibitors: Design, Synthesis, and Anticancer BioevaluationLe Thi Thao, Hwa Kyung Kim, Hoang Kim Ngoc, et al.
RSC Advances|July 23, 2025
Novel quinazoline-triazole-based N-hydroxybenzamides/N-hydroxypropenamides as HDAC inhibitors: design, synthesis, biological evaluation, and docking studiesNguyen Phuong Dung, Hwa Kyung Kim, Nguyen Thi Nga, et al.
International Journal of Molecular Sciences|December 17, 2024
Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr MiceHong Kyung Lee, Hwa Kyung Kim, Ji Yeon Kim, et al.
Bioorganic & Medicinal Chemistry|March 7, 2025
Design, synthesis and biological evaluation of novel hydroxamic acid-derived histone deacetylase inhibitors bearing a 2-oxoindoline scaffold as potential antitumor agentsTran Thi Lan Huong, Hwa Kyung Kim, Nguyen Duc Thien, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2025
Novel 2-mercaptoquinazolinone N-hydroxycinnamamides as histone deacetylase inhibitors: design, synthesis, and anticancer evaluationLe Thi Thao, Hwa Kyung Kim, Nguyen Phuong Ngan, et al.
RSC Advances|July 14, 2026
2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activityTran Thi Lan Huong, Hwa Kyung Kim, Nguyen Anh Thai, et al.
Pageof 1